In acute myeloid leukemia, IGF2BP3 is indispensable for leukemia cell survival by enhancing RCC2 expression through the interaction between IGF2BP3 and m6A sites in RCC2 mRNA [65]. Here, RCC2 is linked to acute myeloid leukemia.